NOT FOR REPRINT
Page Printed from: benefitspro.com/author/profile/gregg-goldfarb
Sign In To follow
Patients who have experienced severe stomach complications from the new class of GLP-1 weight loss drugs are now suing Novo Nordisk and Eli Lilly alleging that the drugmakers misled doctors on the drugs' potential risks.